Editor – Faloon and colleagues describe a 26-year-old man who developed phaeochromocytoma crisis following blunt abdominal trauma and attempted embolisation.1 The patient had a phase of sustained hypotension giving rise to multi-organ dysfunction. Ischaemia of the colon was treated with emergency laparotomy without alpha blockade. Emergency adrenalectomy was performed intraoperatively for a ruptured phaeochromocytoma and retroperitoneal haemorrhage. It is to the credit of the team that this patient survived the episode despite the high mortality associated with this condition.2
We suggest that there are two additional learning points from this case.
Firstly, phaeochromocytoma crisis with sustained hypotension is notoriously difficult to manage and there is normally a significant component of myocardial dysfunction due to catecholamine toxicity. An effective treatment (along with aggressive volume replacement) is some form of mechanical circulatory support such as cardiopulmonary bypass or veno-arterial extracorporeal membrane oxygenation.3,4 The use of this type of circulatory support is strongly associated with improved survival in hypotensive phaeochromocytoma crisis.2 If required, urgent surgery can be performed whilst on mechanical support.5
Secondly, the authors correctly point out that intravenous alpha blockade (phentolamine and phenoxybenzamine) is currently difficult to access in UK. In preference to using no alpha blocking agents, clinicians who find themselves in these circumstances should consider using intravenous magnesium for medical stabilisation.2,6 There is an evidence base for intravenous magnesium7,8 as an alternative to alpha blockade and importantly the drug is familiar to many intensivists due to its critical role in eclampsia treatment.
References
- 1.Faloon S, Venkataraman H, Skordilis K, et al. Lesson of the month 2: Blunt abdominal trauma: atypical presentation of phaeochromocytoma. Clin Med 2018;18:345–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Whitelaw BC, Prague JK, Mustafa OG, et al. Phaeochromocytoma [corrected] crisis. Clin Endocrinol (Oxf) 2014;80:13–22. [DOI] [PubMed] [Google Scholar]
- 3.Banfi C, Juthier F, Ennezat PV, et al. Central extracorporeal life support in pheochromocytoma crisis. Ann Thorac Surg 2012;93:1303–5. [DOI] [PubMed] [Google Scholar]
- 4.Sauneuf B, Chudeau N, Champigneulle B, et al. Pheochromocytoma crisis in the ICU: a french multicenter cohort study with emphasis on rescue extracorporeal membrane oxygenation. Crit Care Med 2017;45:e657–65. [DOI] [PubMed] [Google Scholar]
- 5.Noorani A, Vuylsteke A, Lewis C, et al. A moribund athlete. Lancet 2012;380:74. [DOI] [PubMed] [Google Scholar]
- 6.Vendrell M, Martin N, Tejedor A, et al. Magnesium sulphate and (123)I-MIBG in pheochromocytoma: two useful techniques for a complicated disease. Rev Esp Anestesiol Reanim 2016;63:48–53. [DOI] [PubMed] [Google Scholar]
- 7.Lord MS, Augoustides JG. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth 2012;26:526–31. [DOI] [PubMed] [Google Scholar]
- 8.James MF, Cronje L. Pheochromocytoma crisis: the use of magnesium sulfate. Anesth Analg 2004;99:680–6. [DOI] [PubMed] [Google Scholar]
